Go To TTD's Pre-Market Opening Breakout Watch Stock Lists for Thursday, March 26

Search Engine TTD Reports

Go To Prior Days TTD Reports

Translate to any Language

Go to Video Show - "How to Make Money With Breakout Stocks"

Go to Video Show - "How to Make Money With Breakout Stocks"

Go to Video Show -TTD Performance 2008 Long and Short Plays

{short description of image}

Ticker Tape Digest

Thursday - March 26, 2009

                                          By Leo Fasciocco -- TTD

Ticker Tape Digest presents its daily breakout and Short Selling report. It contains Breakout Stocks and Stocks under Significant Accumulation.

Data is from tape action for the day. These stocks are most suitable for aggressive investors seeking ideal entry points for leading stocks.

These stocks will do very well during bull markets and strong market rallies.

TTD also presents Stocks To Sell or Sell Short. These issues are suitable for aggressive investors willing to take short positions both as trades or for longer-term plays. These stocks

will do very well during bear markets or market corrections

TTD's multi-media updates include a slide-show that presents charts and analysis at midsession. Some times TTD presents feature analysis on stocks and the market. TTD uses Windows Media Files. (WMV).

Quote or chart

TTD also presents a "Breakout Watch List" that is up dated daily. This list consists of key stocks in position to breakout. A close watch of this list can put you in the stock just as it breaks out.

TTD often suggests using stop buy orders to enter. It is very important to buy a breakout stock as close as possible to the break point. The idea is to get "elbow room" if the stock should follow through to the upside. This is very important in being successful in making big money with breakout stocks.

TTD also has  special feature sections on  Educational Tips on Investing.

To email Mr. Leo Fasciocco  leo@tickertapedigest.com.For service, email Beverly Owen owen@tickertapedigest.com. TTD’s Tel: 1-480-926-1680.

Total Buy Breakouts today - 8

Stocks Screened - 8,200

 Bull's Strategy - Breakout list expands as market continues to rally strongly. Bulls be selective.  The major market indicators are bullish. What is needed is more volume, or conviction. The first quarter will end soon and earnings will be coming.

 (Put mouse on Dow chart to see Nasdaq chart)

Long Term Environment for bulls:  Neutral

Market (Daily) - NYSE Bullish, Nasdaq Bullish

Market (Weekly) -NYSE Bullish, Nasdaq Bullish

Market  (Monthly) NYSE Bullish, Nasdaq Bullish

Today's Feature Breakout Stock

Myriad Genetics Inc. (MYGN) - 45.46, up 0.92 - Breakpoint 44.20

Stock A Leader, Net to Jump 66% This Year, TTD Targets 54

                    TTD's Quality Rating of Stock - LANC  - ABOVE AVERAGE

  MYGN, based in Salt Lake City, develops and markets cancer-related predictive medicine products. Annual revenues: $334 million. MYGN, a leader and a stock TTD featured several times, breaks out and clears its base. The move comes after the stock split 2-for-1. The stock was up strongly on Wednesday. That was when MYGN received favorable news that its products were recommended by the American College of Obstetricians.

  So far today, MYGN is trading 2.5 million shares, more than double its normal daily volume of 905,000 shares.

  The stock moved higher in the morning and held most of its gain. TTD's clip of the tape shows a big block of 37,041 shares crossing in the morning. The trade came on a down tick from the prior trade at $46.80, but that trade was only at 100 shares. The prior trades were blocks at $46.55. So, the tape really showed strong institutional accumulation.

 TTD highlighted MYGN at today's video show on the Web. MYGN is also a stock we have been featuring for the past several weeks

  MYGN is a leader. TTD's performance chart shows the stock appreciating 130% the past 12 months. That compares with a 40% drop in the S&P 500 index.

    MYGN works on discovering and developing novel drugs to treat diseases, including cancer and HIV. The firm's genetic tests predict a person's chances of developing breast, ovarian, colon, and skin cancer.

   TTD's long-term chart shows MYGN in a strong up trend the past few years. It did not even feel the bite of the bear market. That is very impressive long-term relative strength.

 TTD's daily chart shows MYGN in a seven-week base following a sharp move higher. The stock did poke out of the base late on Wednesday.  

  Today's move higher is very important in that the stock clears the base convincingly. Being a leader, the stock has performed very well during the stock market's current rally.

   The accumulation - distribution line has turned up. It did weaken in recent weeks, perhaps reflecting profit taking.

  This fiscal year ending June 30, 2009, MYGN's net should jump 66% to $1.70 a share from $1.02 a year ago. The Street was forecasting $1.41 but the estimates have been going up. The net is before adjusting for the stock split.

The stock sells with a price-earnings ratio of  52.

  The p/e would seem high but fits nicely given the earnings growth outlook. Looking out to fiscal 2010, analysts predict an 89% surge in net to $3.21 a share. That would be an acceleration in annual earnings growth. That is very bullish.

  MYGN's revenues grew at 53% in the most recent quarter to $74 million from $48 million a year ago.

  Net for the upcoming fiscal third quarter ending March 31 is expected to come in at 47 cents a share compared with a loss of 10 cents a year ago.

 The company said all five of its molecular diagnostic products are showing good growth.  

  Strategy Opinion:  MYGN has blown out of its base with vigor. TTD is targeting the stock for a move to 54 within the next few months, or sooner. A protective stop can be placed near 41. TTD rates MYGN a very good intermediate-term play provided earnings remain on course.

  Sponsorship: Excellent. The largest fund holder is 5-star rated Fidelity Contrafund with a 2.2% stake. It was a recent buyer of 438,000 shares. Also, 5-star rated Fidelity Advisor New Insights Fund was a recent buyer of 84,000 shares. MYGN has 93 million shares outstanding. Funds hold 39 million shares.

  Insider Activity: Neutral. Insiders have been buyers using stock options. They did  some light selling afterwards. 12 analysts follow the stock, 7 have a buy, up from 6 three months ago.   

                     Stock Performance Chart for 12 months with Quarterly Earnings Markers.


TTD's Profile Rating

Myriad Genetics Inc.  (MYGN) 

TTD Check List Bullish Bearish Neutral
Near 52-week High YES    
Volume Expansion YES  
Tick Volume YES  
Price Trend - Daily YES  
Price Trend - Long Term YES    
Price Daily Spread YES  
Base Structure YES  
Base - A-D YES    
Earnings-Quarterly YES    
Earnings-Long Term YES    
Earnings Outlook YES    
Industry Group YES  
Prior Breakout Success YES    
Fund Sponsorship YES    
Total Score 14 0 0

Timely Breakout Stocks From Tape Action Today

(The “breakout List” gives all stocks breaking out of a base of five weeks or more. These stocks have a good chance to trend higher. However, a stop should be used to avoid those that do not work. (Trading strategy: One should buy breakout stocks at breakpoint by using market order or stop buy.

Charts of Breakout Stocks

                    TTD's Quality Rating of Stock - AIPC  - ABOVE AVERAGE

                    TTD's Quality Rating of Stock - HOTT  - BELOW AVERAGE

                    TTD's Quality Rating of Stock - OPTR  - BELOW AVERAGE

                    TTD's Quality Rating of Stock - OPTR  - BELOW AVERAGE

{short description of image}

Ticker Tape Digest’s

Stocks To “Sell or Short”

Ticker Tape Digest’s Daily List of “Stocks To Sell or Sell Short” ranks stocks well timed to be sold immediately based on daily trading. The list can be used as an alert to reduce current long-term positions.

Shorts from tape action so far today - 3

Stocks Screened - 8,200

Long-Term Environment for bears: Neutral

Bear Side - Small list of breakdown stocks today. Market continues to rally. Bears remain conservative.

List of Stocks To Sell or Short

(Trading strategy: These stocks can be sold short, or if held should be sold. If a stock is sold short, a protective stop buy should be placed. Short plays work best when the stock market is in a down trend.)

TTD’s Feature Bear Play

McCormick & Co. (MKC) - 29.09, off 0.80

Cuts Below Key Support, TTD Sees Drop to 24

  MKC, based in Sparks, Md., is a diversified specialty food company, It produces spices, herbs, seasonings, flavorings and other specialty food products to the entire food industry. Annual revenues: $3.2 billion. MKC's stock breaks below key support today at 30. The stock has been acting weak the past several sessions. So far today, MKC is trading 2 million shares, almost double its normal daily volume of 1.3 million shares.

  MCK's stock headed lower in the morning hiting a bottom near 28.50. It lifted modestly in the afternoon.

  TTD's clip of the tape shows the recent big block trades. One can see the price for the blocks declining from $29.89 to $29. The pattern shows clear institutional selling pressure.

 The company also makes specialty plastic bottles and tubes for food, personal care and other industries. The company operates in three business segments: consumer; industrial; and packaging.

  The stock turned weak recently as the firm lowered its sales outlook. It said sales will be at the low end of it forecast range. This year, the Street is projecting an 11% increase in net to $3.75 a share from $3.38 a year ago.

  TTD's chart shows MKC's stock falling from 40 to 30. It then tried to form a bottom. It was acting well, but recently started to show heavy selling pressure. The stock's TTD momentum indicator (top of the chart) is now bearish. The accumulation - distribution line (bottom of chart) is trending lower. That shows heavy selling pressure.

  Strategy Opinion: TTD is targeting MKC for a drop to 24 within the next few months, or sooner. A protective stop buy can be placed near 31.

TTD columnist Leo Fasciocco has covered the stock market for over 20 years. His articles appear in many publications. He is also a speaker at the Intershow conferences. He has been on television and radio. He is author of many educational articles about stock investing and the book “Guide To High-Performance Investing.”

{short description of image}

For information to subscribe to the Ticker Tape Digest Services call: B. J. Owen at 1-480-926-1680. Distributed by Corona Publishing Enterprises. Ticker Tape Digest Inc. P.O. Box 2044 Chandler, Az. 85244-2044. TTD “Professional Report” is available on the World Wide Web: $100 per month. Password needed. “TTD Professional“ Faxed is $200 per month. The TTD Daily Report is $39.95. Credit cards accepted.

(The information contained has been prepared from data deemed reliable but there is no guarantee of complete accuracy. Ticker Tape Digest Inc. is not affiliated with any broker, dealer or investment advisor. Nothing in this publication constitutes an offer, recommendation or solicitation to buy or sell any securities. Further research is advised. This report is copyrighted and no redistribution is permitted with out permission. Some of the charts are from Telescan, Insight Trading, First Alert and other sources.)